Theranostic Nanoprobes for Rheumatoid Arthritis: From Inflammation Visualization to Guided Precision Therapy

Area of Science:

• Nanomedicine
• Immunology
• Radiology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease with significant joint damage and varied treatment responses.
• Theranostic nanoprobes offer integrated imaging and therapy for RA, moving beyond simple drug delivery.
• These platforms enable targeted delivery, real-time monitoring, and adaptive treatment strategies for RA management.

Purpose of the Study:

• To review the evolution of theranostic nanoprobes for rheumatoid arthritis (RA).
• To outline pathological features enabling joint targeting and inflammation imaging in RA.
• To survey therapeutic strategies integrated with imaging for image-guided intervention and feedback in RA.

Main Methods:

• Review of literature on RA theranostic nanoprobes.
• Analysis of pathological and biological features for targeted imaging.
• Survey of therapeutic modalities coupled with imaging for RA treatment.

Main Results:

• Theranostic nanoprobes are evolving towards integrated imaging-therapy-feedback loops for RA.
• Advances include molecular targeting, inflammation imaging, and image-guided therapeutic delivery.
• Preclinical progress is substantial, but clinical translation faces safety, manufacturing, and regulatory hurdles.

Conclusions:

• Fully integrated theranostic platforms represent a significant advancement over conventional nanoprobes.
• Clinical translation of RA theranostic nanoprobes requires addressing safety, manufacturing, and regulatory challenges.
• Future efforts must focus on nanoparticle design, standardized evaluation, and integration with clinical endpoints for RA.